0001209191-23-056212.txt : 20231121
0001209191-23-056212.hdr.sgml : 20231121
20231121160530
ACCESSION NUMBER: 0001209191-23-056212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231117
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Nicole S
CENTRAL INDEX KEY: 0001993254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 231428059
MAIL ADDRESS:
STREET 1: C/O ASSEMBLY BIOSCIENCES, INC.
STREET 2: 331 OYSTER POINT BLVD., FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (833) 409-4583
MAIL ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-17
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001993254
White Nicole S
C/O ASSEMBLY BIOSCIENCES, INC.
331 OYSTER POINT BLVD., FOURTH FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Manufacturing Officer
0
Common Stock
2023-11-17
4
S
0
477
0.689
D
93774
D
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
/s/ John O. Gunderson, as Attorney-in-Fact
2023-11-21